|
TTC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.470400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.611400E-01 |
| Normal-vs-Stage2 |
2.433400E-01 |
| Normal-vs-Stage3 |
8.748800E-01 |
| Normal-vs-Stage4 |
3.602000E-01 |
| Stage1-vs-Stage2 |
3.702600E-01 |
| Stage1-vs-Stage3 |
9.227000E-01 |
| Stage1-vs-Stage4 |
2.742800E-01 |
| Stage2-vs-Stage3 |
4.471200E-01 |
| Stage2-vs-Stage4 |
1.204580E-01 |
| Stage3-vs-Stage4 |
4.031800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.346000E-01 |
| Normal-vs-AfricanAmerican |
1.210760E-01 |
| Normal-vs-Asian |
6.280400E-01 |
| Caucasian-vs-AfricanAmerican |
2.877800E-02 |
| Caucasian-vs-Asian |
5.971000E-01 |
| AfricanAmerican-vs-Asian |
4.062200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.541200E-01 |
| Normal-vs-Female |
2.885600E-01 |
| Male-vs-Female |
7.698400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.664400E-01 |
| Normal-vs-Extreme_Weight |
9.206200E-01 |
| Normal-vs-Obese |
3.012200E-01 |
| Normal-vs-Extreme_Obese |
9.714000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.669000E-01 |
| Normal_Weight-vs-Obese |
7.195000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.356000E-01 |
| Extreme_Weight-vs-Obese |
3.898000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.370000E-01 |
| Obese-vs-Extreme_Obese |
5.956600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.481400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.415200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.715600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.942200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.660600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.820400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.381100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.530800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.762100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.137700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.173800E-01 |
| Normal-VS-Type2 PRCC |
2.045800E-01 |
| Normal-VS-KIRP CIMP |
5.574400E-01 |
| Normal-VS-Unclassified PRCC |
2.498200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.533700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.947200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.497500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.762000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.619400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.807000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.188000E-01 |
| Normal-vs-N1 |
2.527600E-01 |
| Normal-vs-N2 |
7.515400E-01 |
| N0-vs-N1 |
7.618300E-02 |
| N0-vs-N2 |
6.269600E-01 |
| N1-vs-N2 |
9.891200E-01 |
|
|
